These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 8303790)

  • 1. [New treatment strategies in coronary disease].
    Bourassa MG
    Union Med Can; 1993; 122(6):462-8. PubMed ID: 8303790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
    Hausenloy DJ; Yellon DM
    Heart; 2008 Jun; 94(6):706-14. PubMed ID: 18480348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).
    Reiner Z; Mihatov S; Milicić D; Bergovec M; Planinc D;
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacotherapy of arteriosclerosis and its complications. Effect of ACE inhibitors and HMG-CoA-reductase inhibitors].
    Tschudi MR; Noll G; Lüscher TP
    Schweiz Med Wochenschr; 1997 Apr; 127(15):636-49. PubMed ID: 9198890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factor management: antiatherogenic therapies.
    Gielen S; Sandri M; Schuler G; Teupser D
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S29-36. PubMed ID: 19675434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal medical management of peripheral arterial disease.
    Rice TW; Lumsden AB
    Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of cholesterol-lowering drugs in prevention of coronary heart disease].
    Skałuba Z; Undas R
    Przegl Lek; 1998; 55(7-8):382-7. PubMed ID: 10021881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic interventions in endothelial dysfunction: endothelium as a target organ.
    Cooke JP
    Clin Cardiol; 1997 Nov; 20(11 Suppl 2):II-45-51. PubMed ID: 9422852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current strategies for the prevention of angina in patients with stable coronary artery disease.
    Bhatt AB; Stone PH
    Curr Opin Cardiol; 2006 Sep; 21(5):492-502. PubMed ID: 16900014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The best of coronary artery disease in 1999].
    Gayet JL
    Arch Mal Coeur Vaiss; 2000 Jan; 93(1 Spec No):51-9. PubMed ID: 10721448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of the acute coronary syndrome in Germany: experiences in a German cluster of the GRACE registry].
    Tebbe U; Bramlage P; von Löwis of Menar P; Lawall H; Gaudron P; Lüders S; Klaus A; Lengfelder W; Scholz KH; Maziejewski S; Cuneo A; Hohmann V; Gulba D
    Dtsch Med Wochenschr; 2007 Sep; 132(39):2000-5. PubMed ID: 17882737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibitors, calcium blockers, estrogen and antioxidants in secondary prevention of coronary disease.
    Vogel R
    Can J Cardiol; 1998 Jul; 14 Suppl D():8D-10D. PubMed ID: 9713419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary prevention of coronary heart disease in elderly patients.
    Hanna IR; Wenger NK
    Am Fam Physician; 2005 Jun; 71(12):2289-96. PubMed ID: 15999866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibition in patients with coronary artery disease and preserved left ventricular function Ischemia Management with Accupril post-bypass graft via inhibition of angiotensin-converting enzyme (IMAGINE) compared with the other major trials in coronary artery disease.
    van Gilst WH; Warnica JW; Baillot R; Johnstone D; Calciu CD; Block P; Myers MG; Chocron S; Rouleau JL;
    Am Heart J; 2006 Jun; 151(6):1240-6. PubMed ID: 16781228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
    Hueb W; Lopes NH; Gersh BJ; Soares P; Machado LA; Jatene FB; Oliveira SA; Ramires JA
    Circulation; 2007 Mar; 115(9):1082-9. PubMed ID: 17339566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Secondary prevention of acute coronary syndrome].
    Motomiya T
    J Cardiol; 1999 Mar; 33 Suppl 1():39-43. PubMed ID: 10342135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
    Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.